2024-11-20 23:36:06
The Philippines Has Approved ReCOV For Phase II/III Cinical Trial
Health/ 2023-07-22
The Philippines Has Approved ReCOV For P...

Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial

Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests
Corporate/ 2023-07-24
Seegene Continues to Support Israel'...

SEOUL,South Korea,Jan. 17,2022--Seegene Inc. (KQ 096530),South Korea\'s leading molecular diagnostics company,announced today thatit has del...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release